Sociodemographic disparities in GLP-1RA and SGLT2i use among US adults with type 2 diabetes: NHANES 2005-March 2020

CONCLUSIONS: The use of GLP-1RA/SGLT2i drugs increased over time but remained low in March 2020. Higher education and income, but not race/ethnicity, were associated with GLP-1RA/SGLT2i use.PMID:38193509 | DOI:10.1080/03007995.2024.2303413
Source: Current Medical Research and Opinion - Category: Research Authors: Source Type: research